← FDA DRUG APPROVALS

FDA ANDA · ANDA086155

HYDROCORTISONE

Sponsor: TARO

APPLICATION
ANDA086155
TYPE
ANDA
ORIGINAL APPROVAL
1978-07-24
LATEST ACTION
2005-04-28
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

HYDROCORTISONEDiscontinued
HYDROCORTISONE 1% · CREAM · TOPICAL

Approval history

2005-04-28Labeling · Supplement 42AP
2001-06-20Manufacturing (CMC) · Supplement 39AP
1993-04-29Labeling · Supplement 36AP
1992-11-23Labeling · Supplement 35AP
1992-11-16Labeling · Supplement 34AP
1991-01-23Labeling · Supplement 32AP
1991-01-03Manufacturing (CMC) · Supplement 31AP
1989-12-15Labeling · Supplement 29AP
1989-11-13Labeling · Supplement 28AP
1989-07-31Manufacturing (CMC) · Supplement 27AP
1989-04-26Labeling · Supplement 26AP
1987-01-08Manufacturing (CMC) · Supplement 20AP
1986-01-10Manufacturing (CMC) · Supplement 18AP
1985-11-13Manufacturing (CMC) · Supplement 17AP
1984-10-02Manufacturing (CMC) · Supplement 16AP
1984-07-03Manufacturing (CMC) · Supplement 12AP
1983-08-18Manufacturing (CMC) · Supplement 13AP
1982-07-09Manufacturing (CMC) · Supplement 11AP
1982-06-02Manufacturing (CMC) · Supplement 3AP
1982-06-02Manufacturing (CMC) · Supplement 8AP
1982-06-02Manufacturing (CMC) · Supplement 4AP
1982-06-02Manufacturing (CMC) · Supplement 2AP
1978-07-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →